Back to Search Start Over

Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia.

Authors :
Reeskamp, Laurens F.
Balvers, Manon
Peter, Jorge
van de Kerkhof, Laura
Klaaijsen, Lisette N.
Motazacker, Mahdi M.
Grefhorst, Aldo
van Riel, Natal A.W.
Hovingh, G. Kees
Defesche, Joep C.
Zuurbier, Linda
Source :
Atherosclerosis (00219150). Mar2021, Vol. 321, p14-20. 7p.
Publication Year :
2021

Abstract

Familial hypercholesterolemia (FH) is caused by pathogenic variants in LDLR , APOB , or PCSK9 genes (designated FH+). However, a significant number of clinical FH patients do not carry these variants (designated FH-). Here, we investigated whether variants in intronic regions of LDLR attribute to FH by affecting pre-mRNA splicing. LDLR introns are partly covered in routine sequencing of clinical FH patients using next-generation sequencing. Deep intronic variants, >20 bp from intron-exon boundary, were considered of interest once (a) present in FH- patients (n = 909) with LDL-C >7 mmol/L (severe FH-) or after in silico analysis in patients with LDL-C >5 mmol/L (moderate FH-) and b) absent in FH + patients (control group). cDNA analysis and co-segregation analysis were performed to assess pathogenicity of the identified variants. Three unique variants were present in the severe FH- group. One of these was the previously described likely pathogenic variant c.2140+103G>T. Three additional variants were selected based on in silico analyses in the moderate FH- group. One of these variants, c.2141-218G>A, was found to result in a pseudo-exon inclusion, producing a premature stop codon. This variant co-segregated with the hypercholesterolemic phenotype. Through a screening approach, we identified a deep intronic variant causal for FH. This finding indicates that filtering intronic variants in FH- patients for the absence in FH + patients might enrich for true FH-causing variants and suggests that intronic regions of LDLR need to be considered for sequencing in FH- patients. [Display omitted] • Intronic variants in low-density lipoprotein receptor gene (LDLR) can cause familial hypercholesterolemia (FH) but are often neglected. • A novel approach to detect these FH-causing variants revealed c.2141-218G > A in LDLR. • This variant causes the first ever described occurrence of a pseudo-exon in LDLR. • c.2141-218G > A is the deepest known FH-causing variant to date. • This emphasizes the need to consider whole LDLR gene analysis in FH. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00219150
Volume :
321
Database :
Academic Search Index
Journal :
Atherosclerosis (00219150)
Publication Type :
Academic Journal
Accession number :
149263969
Full Text :
https://doi.org/10.1016/j.atherosclerosis.2021.02.003